The use of biomarkers has been proposed for diagnosing Alzheimer's disease in recent criteria, but some biomarkers have not been sufficiently investigated to justify their routine clinical use. Here, we evaluate in a literature review the clinical validity of amyloid positron emission tomography (PET) imaging using a structured framework...
-
2017 (v1)PublicationUploaded on: April 14, 2023
-
2020 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2020 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2022 (v1)Publication
The present procedural guidelines summarize the current views of the EANM Neuro-Imaging Committee (NIC). The purpose of these guidelines is to assist nuclear medicine practitioners in making recommendations, performing, interpreting, and reporting results of [18F]FDG-PET imaging of the brain. The aim is to help achieve a high-quality standard...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
Purpose: This joint practice guideline or procedure standard was developed collaboratively by the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). The goal of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the...
Uploaded on: April 14, 2023